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ABSTRACT
RecQ helicases are critical for maintaining genome
integrity in organisms ranging from bacteria to
humans by participating in a complex network of
DNA metabolic pathways. Their diverse cellular
functions require specialization and coordination of
multiple protein domains that integrate catalytic
functions with DNA–protein and protein–protein
interactions. The RecQ helicase from Deinococcus
radiodurans (DrRecQ) is unusual among RecQ family
members in that it has evolved to utilize three
‘Helicase and RNaseD C-terminal’ (HRDC) domains
to regulate its activity. In this report, we describe the
high-resolution structure of the C-terminal-most
HRDC domain of DrRecQ. The structure reveals
unusual electrostatic surface features that distin-
guish it from other HRDC domains. Mutation of
individual residues in these regions affects the DNA
binding affinity of DrRecQ and its ability to unwind a
partial duplex DNA substrate. Taken together, the
results suggest the unusual electrostatic surface
features of the DrRecQ HRDC domain may be
important for inter-domain interactions that regulate
structure-specific DNA binding and help direct
DrRecQ to specific recombination/repair sites.
INTRODUCTION
RecQ proteins are DNA unwinding enzymes (helicases)
with critical roles in maintaining genomic integrity in
organisms from every kingdom of life (1). Mutations in
three of the ﬁve human recQ genes have been identiﬁed
as the causes of Bloom’s, Werner’s and Rothmund–
Thomson syndromes (2–4). These syndromes are char-
acterized by susceptibility to several rare cancers and, in
the case of Werner’s and Rothmund–Thomson’s syn-
dromes, developmental defects and premature aging. The
severe consequences of these diseases reﬂect the critical
roles of RecQ helicases in genome maintenance processes
such as DNA replication, recombination and repair.
Research in a variety of model systems continues to
reveal the extensive co-dependencies of genome metabolic
pathways and the role of RecQ proteins in maintaining
genomic integrity through their interactions with a diverse
number of proteins and nucleic acid structures (1,5). The
relatively simple bacterial RecQ family members provide
desirable resources for dissection of the biochemical and
structural features that govern RecQ’s cellular functions.
The bacterium Deinococcus radiodurans is an excellent
model system for studying the roles of RecQ proteins in
genome maintenance. While organisms such as Escherichia
coli, Saccharomyces cerevisiae, mice and humans can
survive modest amounts of g-irradiation [less than a few
hundred Grey (Gy)], D. radiodurans can survive doses as
high as 5000Gy without a loss of viability (6). g-Radiation
is a particularly lethal DNA damaging agent due to its
ability to induce DNA double-strand breaks (DSBs)
during exposure; DSBs are diﬃcult to mend as they leave
notemplate behind for directing DNA repair. Surprisingly,
identiﬁable homologs for the recB and recC genes that
encode the major DSB repair machinery in E. coli are not
found in D. radiodurans (7). This implicates a distinct
recombinational repair pathway (similar to the RecF
pathway from E. coli) as being central to maintaining
genomic integrity in D. radiodurans, as homologs for all
of its genes have been identiﬁed. In recBC
  E. coli, RecF
pathway activation requires mutation in the sbcB gene,
which encodes a 30–50 exonuclease that is also conspicu-
ously absent from the D. radiodurans genome (8). In the
RecF pathway in E. coli, RecQ initiates repair by
unwinding duplex DNA in the 30–50 direction, while the
single-stranded DNA (ssDNA) exonuclease RecJ hydro-
lyzes the 50 strand and the RecA-mediator proteins RecF,
RecO and RecR load RecA onto the 30 strand to drive
homologous recombination (9–11). It remains unclear,
however, the way in which D. radiodurans may have
extended its use of a RecF-like pathway and its constitu-
ents to a greater extent in repairing DNA damage.
The unusual domain architecture of the RecQ protein
from D. radiodurans could help address this question.
The conﬁguration of conserved domains found in almost
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conserved (RecQ-Ct) and HRDC domain (12). In E. coli
RecQ (EcRecQ), the Helicase and RecQ-Ct domains
combine to form a single structural domain that contains
the conserved helicase motifs responsible for RecQ’s
enzymatic activities, a Zn
2+ binding platform for confor-
mational stability, and a winged-helix sub-domain for
interactions with other proteins and DNA structures
(13–17). The HRDC domain forms an independent
helical bundle that is important for structure-speciﬁc
DNA binding (12). DrRecQ contains each of these
domains but has a total of three HRDC domains at its
C-terminus (Figure 1A), a property shared only with
the RecQ family members from Neisseria gonorrhoeae
and Neisseria meningitidis (both non-radioresistant).
Interestingly, each HRDC domain inﬂuences the bio-
chemical functions of DrRecQ diﬀerently (18), raising the
question of how the individual HRDC domains have
achieved such specialization within the framework of their
conserved structural fold.
The structures of isolated HRDC domains from
EcRecQ, S. cerevisiae Sgs1 and Human Werner protein
(WRN) all share a similar overall fold but exhibit
contrasting functions (19–21). The EcRecQ and Sgs1
HRDC domains interact with DNA in a structure-speciﬁc
manner and mutation or deletion of the HRDC can alter
this speciﬁcity without serious consequences for ATP
hydrolysis or helicase activities in the respective protein.
In contrast, the isolated WRN HRDC does not interact
with DNA in vitro and contains an extended loop rich
Figure 1. Structural features of D. radiodurans RecQ HRDC #3. (A) Schematic comparison of the conserved domains of DrRecQ and EcRecQ. Each
protein is comprised of a Helicase, RecQ-Ct and HRDC domain. DrRecQ features two additional HRDC domains at its C-terminus numbered
HRDC #2 and #3, respectively. (B) Stereodiagram of the 2Fo Fc electron density map surrounding P790 in the a3t oa4 loop contoured at 2.0s. All
structural ﬁgures were created using PyMol (39). (C) The a-helical fold of HRDC #3 shown as ribbons. Helix numbers are included in the
representation on the right. (D) Sequence alignment of DrRecQ HRDC domains and HRDC #3’s closest structural homologs. The secondary
structure and corresponding residue numbers in DrRecQ are indicated at the top of the alignment. Structural homologs were identiﬁed using the
DALI search engine (34) and resulting Z-scores are shown following each sequence. Basic residues contacting phosphate in the crystal structure are
shown in blue and acidic residues comprising the acidic patch are in red. Residues conserved in HRDC #3’s structural homologs for the HRDC #3
phosphate binding or acidic patch residues are also colored blue and red, respectively. (E) Phosphate ion present in the HRDC #3 crystal structure.
The position of the phosphate ion and basic residues K805 and R806 are shown on the left side. To the right, a closer view of the surface of HRDC
#3 and the phosphate ion surrounded by an omit map contoured at 5.0s.( F) Electrostatic surface diagram of HRDC #3 in orthogonal views
[for positive (blue) and negative (red) surfaces].
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protein–protein interactions. The structures of E. coli
RNaseD and S. cerevisiae Rrp6 further demonstrate
HRDC domain specialization (22,23). These ribonuclease
structures are of full-length proteins with HRDC domains
and show the tenuous nature of the inter-domain
interactions between their large, catalytic portions and
HRDC domains. In both structures, a single acidic residue
from the HRDC domain mediates contacts with the
remainder of the protein. Mutation of this acidic residue
in Rrp6 alters its structure-speciﬁc nuclease activity,
attesting to the importance of such inter-domain contacts.
The hypothesis suggested by these structures and in vitro
biochemical data is that HRDC domains provide a
malleable scaﬀold upon which to evolve specialized func-
tions through changes to their surface-exposed residues.
Therefore, an understanding of HRDC domain speciali-
zation provides critical details about how RecQ helicases
can perform distinct, yet integrated functions in genome
maintenance.
In this report, we describe the 1.1A ˚ resolution structure
of the regulatory C-terminal-most HRDC domain of
DrRecQ. This domain retains an overall fold similar to
other HRDC domain structures, but features a concen-
trated patch of acidic residues and two sequential basic
residues that ligand a phosphate ion in the crystal struc-
ture. We have examined the roles played by these structural
features by creating individual alanine-substitution muta-
tions in full-length DrRecQ and show that changes in these
regions aﬀect the enzyme’s ability to bind DNA and
unwind a partial duplex DNA substrate but not hydrolyze
ATP in the presence of short ssDNA oligonucleotides. This
is a surprising result given our previously observed increase
in ssDNA-binding aﬃnity and short ssDNA-dependent
ATP hydrolysis upon removal of this domain from
DrRecQ (18). We propose a model where the HRDC
domain’s acidic patch provides a surface for inter-domain
interactions that function to direct DrRecQ binding to
certain DNA structures as a mechanism of self-regulation.
MATERIALS AND METHODS
Cloning, expression and purification ofDrRecQ constructs
and variants
Expression plasmids pMK101 (encoding residues 1–824,
DrRecQ) and pMK108 (residues 751–824, HRDC #3)
were previously described (18). Alanine-substitution muta-
tions in pMK101 were created according to the Quik
Change mutagenesis protocol (Stratagene). The sequences
of all plasmids were conﬁrmed by DNA sequencing.
Plasmids were transformed into BL21(DE3) E. coli
cells, grown at 378C in Luria–Bertani medium supple-
mented with 50mg/ml kanamycin to an OD600=0.6, and
induced to overexpress protein by the addition of 1mM
isopropyl-b-D-thiogalactopyranoside for 4h. Cells were
harvested by centrifugation (10min at 13000g) and stored
overnight at  808C. Cell pellets were resuspended in lysis
buﬀer (20mM Tris, pH 8.0, 500mM NaCl, 10% (v/v)
glycerol, 1mM 2-mercaptoethanol, 1mM phenylmethyl-
sulphonyl ﬂuoride (PMSF), 100mM dextrose and 15mM
imidazole), lyzed at 48C by two passages through a French
press, and clariﬁed by centrifugation (30min at 28000g).
All subsequent steps were carried out at 48C. Soluble
lysate was loaded onto a Ni
2+-NTA column and washed
with 20 column volumes of lysis buﬀer. His-tagged protein
was eluted with 3–6 column volumes of lysis buﬀer
containing 250mM imidazole and dialyzed overnight in
lysis buﬀer lacking imidazole. Preparations of HRDC #3
were digested with thrombin to remove the His-tag
(leaving a Gly-Ser-His sequence at the N-terminus), and
passed over a second Ni
2+-NTA column to remove any
uncleaved protein. The remaining protein was concen-
trated and puriﬁed through a Sephacryl S-100 size
exclusion column (Pharmacia, Uppsala, Sweden) in
10mM Tris, pH 8.0, 500mM NaCl, 10% (v/v) glycerol,
1mM 2-mercaptoethanol, 1mM PMSF and 1mM EDTA.
HRDC #3 fractions were pooled, concentrated to 25mg/
ml, dialyzed against storage buﬀer (10mM Tris, pH 8.0,
400mM NaCl, 40% (v/v) glycerol, 1mM 2-mercaptoetha-
nol, 1mM PMSF and 1mM EDTA), and stored at
 808C. Selenomethionine-incorporated HRDC #3 was
expressed as previously described (24), and puriﬁed
identically to unsubstituted protein except that 1mM
Tris(s-carboxylethyl) phosphine hydrochloride was used
instead of 2-mercaptoethanol in all buﬀers. For DrRecQ
and variants, the Ni
2+-column eluent was dialyzed against
lysis buﬀer lacking imidazole for 4h, diluted 10-fold in
dilution buﬀer (5mM Tris, pH 8.0, 20% (v/v) glycerol,
1mM 2-mercaptopethanol and 1mM EDTA), and
puriﬁed through a Q Sepharose Fast Flow ion exchange
column (GE Healthcare, Uppsala, Sweden) equilibrated in
QFF buﬀer (10mM Tris, pH 8.0, 50mM NaCl, 10% (v/v)
glycerol, 1mM 2-mercaptoethanol and 1mM EDTA) with
elution by gradually increasing the NaCl concentration to
1M. Fractions containing pure protein were pooled,
concentrated to 10mg/mL, dialyzed against storage
buﬀer for 4h, and stored at  808C.
Crystallization of HRDC #3
HRDC #3 was dialyzed against 10mM Tris, pH 8.0
and 50mM NaCl at 48C for 4h. Crystals were grown
by hanging-drop vapor diﬀusion at room temperature by
suspending 1ml of HRDC #3 (3mg/ml) and 1ml of mother
liquor (1.8M Na/K Phosphate, pH 4.0, 100mM Hepes,
pH 7.5) above 1ml of mother liquor. Crystals measuring
 50mm  300mm  500mm formed in one day and
were transferred to a cryoprotectant solution (0.75M Na/
K Phosphate and 25% (v/v) ethylene glycol) prior to being
ﬂash-frozen in liquid nitrogen. Both native and seleno-
methionine-incorporated crystals diﬀracted to 1.1A ˚ reso-
lution with unit cell dimensions a=b=49.98A ˚ ,
c=83.61A ˚ , and space group P41212.
MADphasing and model refinement
The structure of selenomethionine-incorporated HRDC
#3 was solved to a resolution of 1.1A ˚ using multi-
wavelength anomalous dispersion (MAD) phasing. The
automated structure solution package Elves was used
throughout data analysis and map construction (25). Data
were indexed and scaled with MOSFLM (26) and SCALA
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and reﬁned using MLPHARE (29). Interpretable electron
density maps were created following solvent ﬂattening
using DM (30) and the initial model built using ARP/
WARP (31) was adjusted manually using the program O
(32). The model was further reﬁned by multiple iterative
rounds of reﬁnement using REFMAC5 (33) and manual
rebuilding.
Sizeexclusion chromatography
DrRecQ and its variants were dialyzed into 20mM Tris,
pH 8.0, 100mM NaCl, 1mM 2-mercaptoethanol, 1mM
MgCl2 and 4% (v/v) glycerol. Proteins were resolved
through a Superdex 200 gel ﬁltration column (GE
Healthcare) equilibrated in the same buﬀer and plotted
as the absorbance of each sample as a function of its
retention volume in the column. For reference, gel
ﬁltration standards (BioRad, Hercules, CA) were also
run and the position of their elution peaks is indicated at
the corresponding volume in the column.
DNA binding assays
Substrate preparation, measurement of DNA binding by
ﬂuorescence polarization (FP), and calculation of fraction
bound were performed as previously described (18)
for DrRecQ and each of its variants. Proteins were diluted
in 20mM Tris, pH 8.0, 100mM NaCl, 1mM 2-mercap-
toethanol, 1mM MgCl2, 0.1g/l of bovine serum albumin
and 4% (v/v) glycerol and incubated with either a 0.2nM
ﬂuoroscein-labeled 30-base ssDNA (o30, 50-GCGTG
GGTAATTGTGCTTCAATGGACTGAC-30)o r1 n M
ﬂuoroscein-labeled 18bp duplex DNA with a 12 base
30-overhang (dup-30) at room temperature in a total
reaction volume of 100ml. The dup-30 substrate was
created by heating and slow cooling an equimolar mixture
of o30 and o18 (50-AAGCACAATTACCCACGC-30)t o
room temperature. The radio-labeled synthetic Holliday
junction (HJ) substrate was prepared as previously
described by heating and slow cooling a mixture of four
complementary oligonucleotides (18). FP reactions were
measured at 258C using a Panvera Beacon 2000 FP system
with 490nm excitation and 535nm emission wavelengths.
The fraction of substrate bound in each sample was
calculated by setting the anisotropy value of the ﬂuor-
escein-labeled substrate in buﬀer alone (values were  40
millianisotropy (mA) units) to zero and setting the
anisotropy value at 10mM protein concentration (values
were  220mA) to 100% bound. Fluorescence intensity
for all substrates and protein variants did not vary by
>15% across the range of protein concentrations tested
indicating that quantum yield diﬀerences between free
DNA and protein-bound DNA did not signiﬁcantly
inﬂuence the anisotropy measurements. Each reaction
was performed a minimum of three times and plotted as
an average value with error bars corresponding to
1SD. Apparent Kd’s were determined for each individual
dataset and used to calculate their average, standard
deviation and P-values using the MedCalc software
program. Gel-based binding experiments were performed
in buﬀer identical to FP reactions and contained 1nM
of the appropriate radio-labeled substrate. DrRecQ or its
variants were added to the reaction mixture in a ﬁnal
volume of 20ml and incubated at room temperature for
30min. The bound products were resolved through a
6–8% native polyacrylamide gel, dried onto Whatman
paper, and imaged using a Storm 820 Phosphorimager
(Amersham Biosciences, Uppsala, Sweden).
DNA-dependent ATPhydrolysis assays
ATPase assays were performed as previously described
(13). The ATPase activity of each DrRecQ variant was
stimulated by the addition of 0.028–2800nM (nucleotides)
dT28. For longer DNA substrates, assays were performed
with 0.04–2800nM (nucleotides) M13mp18 circular
ssDNA (New England Biolabs, Ipswich, MA). Each
reaction was performed a minimum of three times and
plotted as an average value with error bars corresponding
to 1SD.
Helicase assays
Reaction conditions were as described in (18). Brieﬂy, T4
polynucleotide kinase was used to phosphorylate the
50-end of o18 or oHolliday1 followed by annealing to their
complimentary oligonucleotide(s) by heating and slow
cooling to room temperature. The dup-30 substrate created
contains an 18-bp duplex region and a 12-base single-
strand extension with a 30-end and the synthetic HJ
contains 20-bp duplex arms extending from a central,
four-way junction. Serially diluted DrRecQ variants were
incubated with 1nM substrate for 30min at room
temperature in 20mM Tris, pH 8.0, 50mM NaCl, 1mM
2-mercaptoethanol, 1mM MgCl2, 1mM ATP, 0.1g/l
bovine serum albumin and 4% (v/v) glycerol. For assays
testing ATP dependence, either 1mM ADP or ATPgS
were substituted for ATP in the reaction mixture.
Reactions were quenched by the addition of 11% (v/v)
glycerol, 0.29% SDS, and 5ng of the unlabeled o18
or oHolliday1. Reaction products were resolved through
10–12% native polyacrylamide gel, dried onto Whatman
paper, imaged using a Storm 820 Phosphorimager
(Amersham Biosciences), and quantiﬁed using Image
Quant 5.1 software. The percentage of DNA unwound is
plotted as an average of at least three trials with error bars
corresponding to 1SD from the mean.
RESULTS
Structure ofD. radioduransRecQ HRDC #3
The structure of HRDC #3 was solved to 1.1A ˚ resolution,
making it the highest resolution HRDC domain structure
determined to date. Residues 751–824 of DrRecQ were
built into well-deﬁned electron density maps (Figure 1B)
generated using MAD phasing and solvent ﬂattening. The
ﬁnal structure was reﬁned with good stereochemical and
structural statistics (Table 1).
The overall HRDC #3 structure adopts a globular fold
comprising ﬁve a-helices connected by short loop regions
similar to those of other HRDC domain structures
(Figure 1C). HRDC #3 begins with a long, N-terminal
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hydrophobic loop. This region is ﬂanked by the compact
helix-loop-helix stretch of a3 and a4 that positions a5 into
a close, anti-parallel orientation with a1. A search for
structural homologs of HRDC #3 using the DALI search
engine (34) revealed the strongest structural similarities
(Z-score>7.0) were with the HRDC domains of E. coli
RNaseD [root mean square deviation (r.m.s.d.): 1.2A ˚ for
74Ca atoms], EcRecQ (r.m.s.d.: 1.1A ˚ for 69Ca atoms),
Sgs1 (r.m.s.d.: 2.0A ˚ for 72Ca atoms), Rrp6 (rmsd: 1.7A ˚
for 74Ca atoms) and human WRN (rmsd: 1.4A ˚ for 74Ca
atoms). A sequence alignment of these homologs demon-
strates the low amount of sequence conservation with
HRDC #3 despite the retention of an HRDC domain fold
in these proteins (Figure 1D).
Two distinguishing features within HRDC #3 include
an expansion of ionic interactions among separate helices
and proline residues that restrict loop orientation. An
example of the ionic features is a salt bridge formed
between a1 and a5 through the interaction of E768 and
R813 side chains. These interacting partners are separated
by 45 residues in primary structure, but folding of HRDC
#3 allows their close association (2.9A ˚ ). Among HRDC
#3’s close structural homologs, E768 is found in RNaseD
and EcRecQ, but the interaction with a5 is not formed
in these HRDC domains. For R813, the Sgs1 HRDC
domain has an analogous arginine residue that was
implicated in DNA binding by NMR chemical shift
experiments (21). Therefore, the usage of this arginine to
form an ionic interaction in HRDC #3 could limit its
ability to interact with DNA, consistent with our previous
observation that isolated HRDC #3 has a very low aﬃnity
for DNA (18,21). In contrast to this variable inter-helix
bridge, a prominent polar interaction that occurs between
R762 and N779 is conserved across HRDC #3’s closest
structural homologs. The proximity of these residues
results from the hydrophobic loop connecting a1t oa2
that folds the structure back onto itself. Due to the high
relative B-factors of this exposed hydrophobic region, this
ionic interaction may be favored as a means to stabilize
the HRDC framework. Mutation of the arginine at this
position in EcRecQ HRDC results in a greater than
10-fold reduction in ssDNA binding, suggesting this may
be a weak interaction in those HRDC domains that bind
nucleic acids strongly (19). The last notable interaction
occurs between R791 and N819 connecting the loop
following a3t oa4. This interaction is not seen in HRDC
#3’s structural homologs, although the loop contains a
proline (P790) that is strictly conserved across these
diﬀerent HRDC domains (Figure 1D). In each structure,
this proline residue kinks the loop inwards; inverting the
surrounding residues to project their side chains outwards.
In HRDC #3, this restricts the loop conformation,
allowing the inter-helix bridge to form between R791
and N819. A similar interaction is seen in the WRN
HRDC domain structure although the arginine residue in
its loop is positioned to interact with a1 instead of a4a sa
proposed means to stabilize its elongated N-terminal a1
(20). HRDC #3 also appears to use a proline (P800) to
restrict the loop conformation between a4 and a5
containing the conserved hydrophobic residues V799 and
L802. While the latter residues are conserved among other
HRDC domains, the proline is not and may further
contribute to HRDC #3’s stability by locking these
hydrophobic residues into the interior of the domain.
Phosphate bindingin theHRDC 3crystal structure
Electron density maps of HRDC #3 displayed a well-
ordered, electron-dense ligand bound near the C-terminus
of a1 (Figure 1E). The tetrahedral shape of the density
suggested that a phosphate ion from the crystallization
buﬀer was bound to HRDC #3 in the crystal lattice. The
phosphate ion bridges HRDC #3 symmetry mates within
the lattice, with residues K805 and R806 of one molecule
and K767 of the adjacent symmetry mate liganding the
ion. Phosphate association at this position suggested that
these residues could be involved in forming contacts to the
phosphate backbone of DNA, which we tested below.
Although the isolated HRDC #3 binds DNA with low
aﬃnity (Kd,app>10mM) (18), it is possible that in the
context of the full-length protein this region is capable of
contacting DNA. Evidence for such an interaction is
provided by observations made in RNaseD, EcRecQ and
Sgs1 HRDC domains. The crystal structure of RNaseD
contains a sulfate ion in a similar position to the HRDC
#3 phosphate, and it is also bound by an arginine residue
that is located in a similar region to R806 (23). In Sgs1, the
analogous lysine–arginine pair display large NMR
Table 1. Data collection, phasing and reﬁnement statistics
Peak   Low energy  
Data collection
Wavelength (A ˚ ) 0.9797 0.9999
Resolution range (A ˚ ) 83.6–1.1 (1.16–1.10) 83.6–1.1 (1.16–1.10)
Completeness (%) 96.6 (78.7) 94.0 (64.8)
Total reﬂections 275,102 261,308
Unique reﬂections 42,318 41,193
<I/sI> 13.8 (1.8) 16.9 (2.4)
Rsym
a (%) 6.7 (41.9) 5.9 (27.1)
Phasing
Figure of merit 0.376; 0.613
after solvent
ﬂattening
Reﬁnement
Resolution (A ˚ ) 20–1.1
Rwork/Rfree
b (%) 17.7/19.4
Rms deviations
Bonds (A ˚ ) 0.010
Angles (8) 1.23
Ramachandran plot (%)
Most favored 95.6
Allowed 4.4
Generously allowed 0.0
Disallowed 0.0
aRsym=j|Ij   <I>|/Ij where Ij is the intensity measurement for
reﬂection j and <I> is the mean intensity for multiply recorded
reﬂections.
bRwork, free=||Fobs|   |Fcalc||/|Fobs|, where the working and free R
factors are calculated using the working and free reﬂection sets,
respectively. The free R reﬂections (5% of the total) were held aside
throughout reﬁnement.
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consistent with DNA binding to this surface (21).
Furthermore, of all the residues in the Sgs1 HRDC
domain that responds to the addition of DNA in this
manner, only the lysine residue is conserved with the
WRN and Bloom’s protein (BLM) HRDC domains.
Interestingly, this lysine is required in BLM for eﬃcient
dissolution of synthetic double HJs (35). In the isolated
EcRecQ HRDC domain, mutation of K587 correspond-
ing to HRDC #3 R806 results in a 10-fold decrease in
ssDNA-binding aﬃnity by electrophoretic mobility shift
assay (36). Thus, comparison of HRDC #3’s structural
features with its homologs suggests it may play a role in
DNA binding in DrRecQ.
The HRDC #3domain containsaprominent acidic patch
The most striking feature unique to HRDC #3 is the
concentration of acidic residues on a surface comprising
the terminal portions of a1 and a5 (Figure 1F). Several
acidic residues including D753, E756, E760, E764 and
D816 contribute to the domain’s large electronegative
surface. These residues are not conserved among other
HRDC domains, including HRDC #1 and #2 in DrRecQ
(Figure 1D). Furthermore, the calculated isoelectric point
(pI) of HRDC #3 is 4.6, another property that contrasts
sharply with HRDC #1 (pI=7.4) and HRDC #2
(pI=8.8). The HRDC #3 structure shows that many of
these acidic residues are clustered on one face of the
domain (Figure 1F), suggesting that the acidic character
of HRDC #3 could be tailored for a speciﬁc function in
DrRecQ. This observation raised the possibility that the
acidic patch of HRDC #3 could be a site for inter-domain
interactions that are similar to HRDC domains in
RNaseD and Rrp6 (22,23). Such an interface between
HRDC #3 and the rest of DrRecQ could help explain our
earlier observations that the presence of this domain
reduces the protein’s ability to bind ssDNA and hydrolyze
ATP in a DNA-dependent manner (18).
DNA binding by DrRecQ variants
To test whether residues involved in phosphate binding
or formation of the acidic patch aﬀect the function of
DrRecQ, we created single alanine-substitution muta-
tions altering these regions in the full-length protein
(Figure 2A). Puriﬁed DrRecQ variants were tested in vitro
for their ability to bind DNA by observing DrRecQ-
dependent changes in the ﬂuorescence anisotropy of a
ﬂuoroscein-labeled ssDNA or dup-30 DNA. Gel-shift
analysis was used to test binding to synthetic HJ DNA
because we had previously observed multiple binding
events by DrRecQ variants using ﬂuorescence anisotropy
that made interpretation of the results diﬃcult (18). Our
hypothesis was that basic residues that bound phosphate
in the HRDC #3 crystal structure could play roles in DNA
binding and that their mutation to alanine could result in
decreased DNA binding aﬃnity. DrRecQ bound ssDNA
with a Kd,app of 1.3 0.5nM (Figure 2B, Table 2).
Substitution of alanine at either K805 or R806 resulted
in modest 2-fold binding defects (Kd,app of 2.5 0.6nM
and 2.7 0.2nM for each mutant, respectively) although
only the defect in R806A ssDNA binding appeared to
be statistically signiﬁcant, with a P-value of 0.0078
(Figure 2B, Table 2). Likewise, the Kd,app for binding to
the dup-30 substrate was weakened 2-fold or less from
143.6 23.4nM for DrRecQ to 279.0 17.7nM for
K805A and 177.9 98.3nM for R806A (Figure 2C,
Table 2). Only the K805A mutant showed a statistically
signiﬁcant diﬀerence from WT on the dup-30 substrate
(P=0.0013). We also observed modestly reduced HJ
binding aﬃnity for the K805A variant relative to DrRecQ,
suggesting mutation of this residue compromises stable
association with HJ DNA (Figure 3). These results
indicate that phosphate binding residues in HRDC #3
could play a minor role in DNA binding, although the
relatively modest binding defects of their variants suggest
the remainder of DrRecQ provides the major DNA bind-
ing surfaces on the enzyme.
We next determined the eﬀect of mutations in the acidic
patch of HRDC #3 to test our hypothesis that these
residues help form an inter-domain interface that is
important for enzyme function. If such inter-domain
interactions position HRDC #3 properly, we hypothesized
that mutations in this region could alter DrRecQ DNA
binding. We observed a strong defect in binding to both
ssDNA and dup-30 following alanine-substitution at
D816. The D816A mutant had a Kd,app of 6.9 0.7nM
for ssDNA, an approximate 5-fold decrease in aﬃnity
relative to wild-type (WT) DrRecQ (Figure 2D, Table 2).
This variant also had a 10-fold decrease in dup-30 binding,
with a Kd,app of 1282.2 95.7nM (Figure 2E, Table 2) and
a  5-fold decrease in ability to shift HJ DNA (Figure 3).
Mutations in other residues comprising the acidic patch
did not have a signiﬁcant eﬀect on binding to ssDNA or
HJ DNA (Table 2, Supplementary Figure 1A, Supple-
mentary Figure 2), although we did observe a 2–4-fold
reduction in their aﬃnity for the dup-30 substrate
(Supplementary Figure 1B, Table 2). The defects observed
for these variants are not likely to be due to diﬀerences in
oligomeric state or aggregation of the proteins since
DrRecQ, R806A and D816A at concentrations >100mM
all displayed equal mobility by analytical gel ﬁltration in
buﬀer conditions identical to our DNA binding reactions
(Supplementary Figure 3). In addition, gel-shift assays
testing binding of DrRecQ and D816A to ssDNA and
dup-30 show these proteins do not have observable diﬀe-
rences in oligomeric state when bound to DNA and are
consistent with a single-site binding model (Supplemen-
tary Figure 1C and D). The DNA binding defects of the
acidic patch mutants are consistent with the hypothesis
that they make interactions important for the proper
function of DrRecQ. In particular, D816 appears to be
important for proper DrRecQ function. Since each of
these mutations resulted in a more pronounced dup-30
binding defect than ssDNA or HJ binding, it is possible
that interactions formed by these residues in HRDC #3
help impart substrate speciﬁcity to DrRecQ.
DNA-dependent ATPhydrolysis by DrRecQ variants
To examine the enzymatic activity of the DrRecQ var-
iants, we ﬁrst tested their DNA-dependent ATP hydrolysis
3144 Nucleic Acids Research, 2008, Vol. 36, No. 9activities (Figure 4). We expected that if any of the
mutated residues contributed to the eﬃcient binding of
ssDNA or conformational changes associated with the
active enzyme that their rate of ATP hydrolysis would
change accordingly. Each of the DrRecQ variants in the
phosphate-binding site (Figure 4A) and the acidic patch
variant D816A (Figure 4B) catalyzed ATP hydrolysis at
similar maximal rates and were activated by dT28 in a
manner that was indistinguishable from WT DrRecQ.
Likewise, we observed no diﬀerences between DrRecQ
and the other acidic patch mutants in their ability to
hydrolyze ATP in this assay (Supplementary Figure 4A).
These results indicate that the variants are competent
to recognize ssDNA, and hydrolyze ATP despite the
observation that several (K805A, R806A and D816A) had
defects in ssDNA binding. These results may be speciﬁc to
shorter oligonucleotides, since performing the assay in the
presence of M13mp18 circular ssDNA showed that the
D816A had a greater activity than DrRecQ and was not
saturated at higher DNA concentrations, suggesting there
may be diﬀerences in how this variant binds and trans-
locates along DNA (Supplementary Figure 4B).
Figure 2. DrRecQ variants have reduced aﬃnity for ssDNA and dup-30 DNA. (A) The positions of alanine-substitution mutations are indicated on
ribbons (left) and surface (right) representations of the HRDC #3 structure. Residues in close proximity to a phosphate ion in the crystal structure
are shown in blue, with those comprising the acidic patch in red. (B–E) Fraction of DNA bound with either ssDNA (B and D) or dup-30 (C and E)
by DrRecQ variants with mutations in the phosphate binding site (B and C) or D816 in the acidic patch (D and E). DrRecQ (closed diamonds),
K805A (open squares), R805A (closed circles) and D816A (open circles). A trend line for DrRecQ is shown in each plot for reference.
Nucleic Acids Research, 2008, Vol. 36, No. 9 3145The increase in D816A ATPase activity on long ssDNA is
similar to the change observed upon removal of HRDC #3
from DrRecQ on the short dT28 substrate (18).
Helicase activity ofDrRecQ variants
Finally, we tested the ability of the DrRecQ variants to
unwind synthetic dup-30 and HJ DNA substrates. These
are two of the preferred substrates for DrRecQ unwinding
in vitro and could be structures targeted by the enzyme
in vivo (18). Since helicase activity integrates both DNA
binding and ATP hydrolysis, we were interested to see if
any of our DrRecQ variants would unwind DNA diﬀe-
rentially. DrRecQ unwound half of the dup-30 substrate at
a concentration of  13pM in an ATP-dependent manner
(Figure 5A, Supplementary Figure 5A and B). Figure 5A
also shows that R806A, but not K805A, exhibits a defect
( 2.5-fold) in its ability unwind the dup-30 substrate,
suggesting this residue could play a minor role in DNA
unwinding. These variants were as proﬁcient as DrRecQ
in unwinding HJ DNA (Supplementary Figure 6). The
D816A variant showed an apparent increase in its ability
to unwind dup-30 DNA at low concentrations (Figure 5B)
that we attribute to normalization of the data and did not
observe for other acidic patch variants (Supplementary
Figure 7A). Interestingly, when we repeated the assay at
salt concentrations identical to the DNA-binding assays,
the D816A variant had a decreased ability to unwind
dup-30  50-fold (Supplementary Figure 7B). At higher
Figure 3. The D816A and K805A mutants have defects in synthetic HJ binding. Increasing concentrations (1.6nM, 8nM, 40nM, 200nM, 1mM)
of DrRecQ, K805A and D816A added to a synthetic HJ substrate. The position of the wells and the unbound substrate is indicated on the left side.
Figure 4. Variants in DrRecQ HRDC #3 do not aﬀect DNA-dependent
ATP hydrolysis with short ssDNA. The rate of ATP hydrolysis for
DrRecQ and (A) phosphate-binding site variants K805A and R806A
and (B) acidic patch variant D816A are plotted as a function of ssDNA
concentration (in nucleotides). DrRecQ (closed diamonds), K805A
(open squares), R806A (closed circles) and D816A (open circles).
Table 2. Statistical comparison of DrRecQ variant UNA binding
Protein Kd,app
a,c SD
a P-value
a,d Kd,app
b,c SD
b P-value
b,d
DrRecQ 1.3 0.5 – 143.6 23.4 –
D753A 1.6 0.1 0.3134 408.6 23.6 .0002
E756A 1.2 0.2 0.6716 205.0 21.6 .0289
E760A 0.8 0.2 0.1372 278.7 38.2 .0064
E764A 1.0 0.2 0.3873 319.1 17.7 .0005
K805A 2.5 0.6 0.0586 279.0 17.7 .0013
R806A 2.7 0.2 0.0078 177.9 98.3 .5888
D816A 6.9 0.7 0.0004 1282.2 95.7 <.0001
assDNA binding (in nM).
bdup-30 binding (in nM).
cMean Kd,app of three independent trials.
dCalculated using independent samples t-test (MedCalc).
3146 Nucleic Acids Research, 2008, Vol. 36, No. 9salt concentrations, DrRecQ unwound half the dup-30
DNA at 80pM while the D816A variant required 240pM
for 50% unwinding. This is consistent with its defect
in dup-30 binding by FP and gel-shift assay at these
salt concentrations. In contrast, DrRecQ’s helicase activ-
ity was only reduced 6-fold at higher salt concentrations
demonstrating that the D816A mutant is particularly
sensitive to the ionic strength of the reaction conditions.
All of the acidic patch variants unwound HJ DNA as well
as DrRecQ (Supplementary Figure 6). Therefore, the
binding defect we observed for the D816A variant on HJ
DNA by gel shift does not seem to aﬀect its unwinding
activity on this substrate.
DISCUSSION
Determining how the conserved domains of RecQ family
members are specialized in their distinct functions is
critical to our understanding of their biological roles. In
this report, we describe the high-resolution structure of the
C-terminal-most HRDC domain of D. radiodurans RecQ.
This domain adopts a similar overall fold to other
HRDC domains but contains a number of additional
intra-domain interactions and proline residues that con-
tribute to its compact tertiary structure. We observed a
well-ordered phosphate ion bound between HRDC #3
symmetry mates contacted by basic residues homologous
to those involved in DNA binding in EcRecQ, Sgs1 and
BLM. Mutation of these residues to alanine in DrRecQ
modestly decreased the enzyme’s ability to bind DNA but
had no eﬀect on short-ssDNA-dependent ATPase activity
or, in the case of R806A, to unwind a dup-30 substrate.
These results demonstrate a possible minor role for
HRDC #3 in DNA binding, although it is clear that the
major DNA-binding and catalytic functions lay elsewhere
in the protein. HRDC #3 also features a prominent acidic
patch that arises from the clustering of ﬁve acidic residues
near its N- and C-termini. Mutation of D816 leads to
defect in binding to several DNA substrates, whereas
individual mutation in other acidic patch residues results
in decreased DNA binding only to a dup-30 substrate.
Each of the acidic patch variants was comparable to WT
DrRecQ in ATP hydrolysis on short ssDNA and DNA
unwinding assays with the exception of the D816A
variant, which showed a marked salt-sensitivity to its
dup-30 DNA unwinding activity. Together, these data
suggest that the acidic patch (D816 in particular) could
play a role in properly positioning HRDC #3 for binding
and unwinding certain DNA structures. Such acidic
HRDC interfaces have been observed previously in the
RNaseD and Rrp6 structures, each of which relies upon a
single acidic residue to dock the HRDC domain against
the catalytic domain of the protein (22,23), as is described
in greater detail subsequently. Collectively, these struc-
tural features demonstrate how HRDC domains have
diverged and support the hypothesis that electrostatic
diﬀerences modulate the activities of HRDC domains.
Afunctional role in DNA binding by HRDCdomains
isconserved inenzymes acting on nucleic acids
Retention and proliferation of HRDC domains in
enzymes found throughout the kingdoms of life attests
to their utility as key components in nucleic acid meta-
bolism. These domains appear to provide structure
speciﬁcity to RecQ DNA binding in a way that could
help diﬀerentiate their functions in organisms that have
several RecQ homologs. Structural descriptions of HRDC
domains have provided a much-needed physical explana-
tion for the in vitro and in vivo data indicating their
importance to RecQ family members, ribonucleases and
polymerases. From these data, a model emerges wherein
cells have taken advantage of the functional plasticity
of HRDC domains to evolve distinctive roles for the
domains in diﬀerent protein contexts.
The high-resolution structures of several HRDC
domains have revealed how clustered electrostatic features
on the domain surface can be important for the domain’s
function. Solution of the Sgs1 HRDC domain structure
ﬁrst described its use of a basic patch to interact with
DNA and showed by homology modeling the lack of
conservation of this surface in BLM and WRN HRDC
domains (21). The recent crystal structure of the WRN
HRDC domain conﬁrmed this ﬁnding by revealing a large
Figure 5. DrRecQ variants have diﬀering helicase activities. The
fraction of dup-30 DNA unwound by DrRecQ, (A) phosphate binding
site variants K805A and R806A, and (B) acidic patch variant D816A
are plotted as a function of protein concentration (0.3pM to 300nM).
DrRecQ (closed diamonds), K805A (open squares), R806A (closed
circles) and D816A (open circles). A trend line for DrRecQ is shown
for reference.
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distinctive features (20). Homologs in bacteria such as the
RNaseD and EcRecQ HRDC domains feature their own
patterns of acidic and basic residues. In the latter, several
of these basic residues form a major ssDNA binding site
on EcRecQ (19). In addition, structures of the HRDC
domains from Rrp6 and sub-complexes of S. cerevisiae
RNA polymerase III have provided examples of specializ-
ing surface charges that form interfaces with other parts of
the protein (22,37).
The structures of HRDC domains from Sgs1, EcRecQ
and DrRecQ have each led to further investigation of
conserved basic residues near the N-terminus of a5. The
K805A and R806A mutations in DrRecQ exhibit modest
defects in binding to ssDNA, dup-30 and HJ substrates
(Figure 2B and C, Supplementary Figure 2). In the case of
DrRecQ HRDC #3, R806A also seems to play a role in
DNA unwinding. An analogous lysine residue to K805A
in Sgs1 undergoes a large chemical shift by NMR upon
the addition of partially duplex DNA (21), and in BLM is
required for eﬃcient dissolution of synthetic double HJ
(35). Moreover, mutation of the analogous residue in
EcRecQ (K587) results in a 10-fold reduction in ssDNA
binding aﬃnity. Therefore, it appears that this region of
the HRDC fold has retained some involvement in DNA
binding in DrRecQ despite specialization of other parts of
the domain.
Possible functions of theHRDC #3 acidicpatch
We have previously demonstrated that truncation of the
protein’s C-terminal HRDC domains alters its biochem-
ical activities and show here the structure of HRDC #3
has a prominent acidic patch that is not conserved in any
of its closest structural homologs. There is compelling
evidence for inter-domain interactions involving HRDC
domains wherein acidic residues from the HRDC element
form critical ionic interfaces with the catalytic portions of
the proteins. Two examples come from the RNaseD and
Rrp6 proteins. The HRDC domains of these related ribo-
nucleases associate with the rest of the molecule primarily
through an interaction comprising a single acidic residue
from the HRDC domain. Mutation of the acidic residue
or its interaction partners forming the inter-domain
interactions in Rrp6 results in an inability to properly
process the 30-end of only a subset of its target RNAs
without aﬀecting its catalytic activity (22,23). We observe
a similar outcome upon mutation of residues in the
HRDC #3 acidic patch, where ssDNA and HJ binding is
unaﬀected by most mutations but binding to a dup-30
DNA is reduced. In addition, the inter-domain interac-
tions in RNaseD bury very modest surface areas for each
of its HRDC domains (270A ˚ 2 and 500A ˚ 2), respectively
(23). Both HRDC #3 and its closest structural homolog,
RNaseD’s N-terminal HRDC domain, are tethered to
their neighboring domains through an extended linker rich
in proline and glycine residues. These observations attest
to the mobility of HRDC domains that could allow for
reorientation following substrate recognition or catalysis
in DrRecQ.
Based upon the results described in this work and the
compelling similarities with earlier studies of HRDC
domains in other systems, we propose that the acidic
patch on HRDC #3 could function by forming an inter-
action surface that is complementary to a basic site on
DrRecQ. In this model, an ionic interface buries HRDC
#3’s acidic patch against the remaining portion of
DrRecQ; such an interaction could orient HRDC #3 so
that it inhibits DNA binding by the helicase domain to
attenuate ATP hydrolysis and subsequent unwinding.
Indeed, truncation of HRDC #3 from DrRecQ increases
its aﬃnity for ssDNA and its rate of ssDNA-dependent
ATP hydrolysis (18). When positioning of HRDC #3 is
disrupted (e.g. by mutation of D816), the domain loses
some of its ability to regulate DrRecQ function. Evidence
for this comes from observations that mutation of D816
increases ATPase activity of DrRecQ on long DNA
substrates [similar to removing the domain entirely on
short ssDNA (18)] and sensitizes DrRecQ to elevated salt
concentrations in helicase assays. A mechanism of self-
regulation such as this may limit the processivity of
DrRecQ or alter the DNA structures upon which it acts.
Such eﬀects could be favorable in D. radiodurans, which is
believed to have been selected to tolerate desiccation
and ﬂuctuating intracellular conditions that damage DNA
and lead to chronic accumulation of aberrant DNA
structures (38).
The structure of HRDC #3 presented here highlights
several features that are unique to this domain and sug-
gests how its regulatory function is manifest. Future
experiments designed to test association among the
domains of DrRecQ will be important for resolving how
it has expanded use of HRDC domains to modulate its
function in D. radiodurans. It will be intriguing to examine
HRDC function in other model systems as well to
determine how multiple HRDC domains aﬀect the cellular
functions of RecQ family members beyond D. radiodurans.
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Supplementary Data are available at NAR Online.
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